Scope & Objective:
A large US base Pharma Company, wanted DelveInsight to support them by providing a detailed CAR-TCR Summit coverage of novel CAR-T Cell Therapies for the B-Cell Malignancies, including the emerging product analysis, developmental activities, safety and efficacy data, product milestones, future plans and KOL insights.
Congress Coverage Support:
- DelveInsight supported the client by creating a focused conference coverage plan in order to gain in-depth assessment of the novel CAR-T Cell Therapies
- In addition to this DelveInsight also conducted primary research in order to cater the KOL and Stakeholder insights around the cell therapy
- High-priority sessions were selected for more focused live coverage
Congress Plan:
- The team extracted and classified sessions by priorities
- Captured detailed presentations and understand the business insights
- KITs and KIQs were aligned with the client’s strategic needs
Outcome:
- The deliverables enabled the client to proactive response to competitor activities in the B-Cell Malignancies disease area presented at CAR_TCR Summit
- Senior internal stakeholders were timely informed of the latest business updates